Very early researchUnknownNCT04074564What this trial is testingMASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue SarcomaWho this might be right forSarcoma HRYZ Biotech Co. 60
Large-scale testing (Phase 3)Study completedNCT00354744What this trial is testingHigh-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaWho this might be right forSarcoma Children's Oncology Group 109
Early research (Phase 1)Study completedNCT00003081What this trial is testingCombination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or RhabdomyosarcomaWho this might be right forSarcoma Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802652What this trial is testingDoxorubicin With or Without DT-7012 in Advanced Soft Tissue SarcomaWho this might be right forUndifferentiated Pleomorphic Sarcoma (UPS)Dedifferentiated Liposarcoma (DDLPS) Gustave Roussy, Cancer Campus, Grand Paris 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05688280What this trial is testingIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STSWho this might be right forMetastatic Solid TumorColon CancerNonsmall Cell Lung Cancer+1 more Immunophotonics, Inc. 42
Early research (Phase 1)Looking for participantsNCT03721068What this trial is testingStudy of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory OsteosarcomaWho this might be right forNeuroblastomaOsteosarcoma UNC Lineberger Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT02573259What this trial is testingA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsWho this might be right forPart 1MELANOMASCCHN+6 more Pfizer 147
Testing effectiveness (Phase 2)UnknownNCT04690725What this trial is testingTQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN LossWho this might be right forSafety IssuesEfficacy, Self Peking University People's Hospital 29
Testing effectiveness (Phase 2)Study completedNCT03590210What this trial is testingCombined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue SarcomasWho this might be right forMetastatic Adult Soft Tissue Sarcoma University Medicine Greifswald 92
Testing effectiveness (Phase 2)Study completedNCT03433183What this trial is testingSARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath TumorsWho this might be right forMalignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1 Sarcoma Alliance for Research through Collaboration 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994What this trial is testingUlixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00053794What this trial is testingPerifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaWho this might be right forEndometrial CancerSarcoma NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Looking for participantsNCT05985161What this trial is testingSelinexor in People With Wilms Tumors and Other Solid TumorsWho this might be right forWilms TumorRhabdoid TumorMalignant Peripheral Nerve Sheath Tumors+4 more Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00003745What this trial is testingChemotherapy in Treating Children With Recurrent or Refractory SarcomasWho this might be right forSarcoma National Cancer Institute (NCI) 125
Early research (Phase 1)Ended earlyNCT00089245What this trial is testingRadiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsNeuroblastomaSarcoma Y-mAbs Therapeutics 177
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Testing effectiveness (Phase 2)Study completedNCT04095208What this trial is testingCombination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyWho this might be right forSoft Tissue Sarcoma AdultAdvanced Cancer Institut Bergonié 68
Early research (Phase 1)Study completedNCT04833582What this trial is testingAzenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With OsteosarcomaWho this might be right forOsteosarcoma K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 31
Testing effectiveness (Phase 2)Looking for participantsNCT07410676What this trial is testingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsWho this might be right forCancerSarcomaLeukaemia+12 more Essen Biotech 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06500091What this trial is testingTQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid TumorsWho this might be right forSoft Tissue SarcomaMelanoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 54